Investors should always be on the lookout for insights that could give them an edge in the stock market, and one potential source of such information is insider buying activity. When company insiders, such as executives or board members, buy shares of a company’s stock, it can be seen as a vote of confidence in the company’s prospects. Publicly available insider buying information can provide valuable clues about which stocks may be worth considering for investment.
Here are three stocks recently purchased by C-level insiders –
Motorcar Parts of America, Inc. – SYM: MPAA
Recent Price: $6.78
Insider Action: 4 insiders buy $1.1 mil in shares
Description: Motorcar Parts of America, Inc. manufactures, remanufactures, and distributes heavy-duty truck, industrial, marine, and agricultural application replacement parts in the United States. Motorcar Parts of America, Inc. was incorporated in 1968 and is based in Torrance, California.
Wall Street legend warns: “A new dawn is coming”
He called the Priceline collapse in 2012, the 2020 crash, and the 2022 bear market. Now he says a new dawn is coming to U.S. stocks. It’s time to throw out the investment blueprint of the last decade and prepare for a massive shift. If you’ve lost money over the past two years, this changes everything.
Crescent Energy Company – SYM: CRGY
Recent Price: $12.25
Insider Action: 4 insiders buy $164K in shares
Description: Crescent Energy Company, an energy company, acquires, develops, and produces crude oil, natural gas, and natural gas liquids (NGLs) reserves. The company holds a portfolio of oil and natural gas assets in key proven basins, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con in the United States. The company is based in Houston, Texas.
8 Years, 97% Win Rate: The Secret? 10 Minutes on Tuesdays…
Imagine winning 97% of your trades over an 8-year period. Sounds impossible, right?
But that’s exactly what millionaire trader Jim Fink has achieved thanks to a simple trade that takes just 10 minutes each Tuesday.
No need to spend hours glued to your phone/screen watching and waiting for the perfect buy/sell moment…
He’s developed a unique approach that has allowed him to consistently win trade after trade, even in the most volatile markets.
Discover the secrets behind his strategy in this exclusive tell-all video!
Journey Medical Corporation – SYM: DERM
Recent Price: $3.32
Insider Action: 4 insiders buy $520K in shares
Description: Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Zilxi, a topical minocycline treatment for inflammatory lesions; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.
One ticker… one trade… every week.
The fast-hitting profit potential is extraordinary.
Learn More Here!